Form D/A — Nia Therapeutics, Inc.
0001758725-26-000002 · filed Jun 3, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Health Care filings
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Reported offering amount
- $26,499,997
- Reported amount sold
- $23,573,844
- Minimum investment
- $50,000
- Investors
- 37
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Nia Therapeutics, Inc.
- CIK
- 1758725
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 119 BRAINTREE ST. UNIT 703
ALLSTON, MA 02134 - Phone
- 2675607402
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Daniel Rizzuto · Executive OfficerAllston, MA Find on LinkedIn ↗
-
Daniel Utin · Executive OfficerAllston, MA Find on LinkedIn ↗
-
Larry Greenberg · DirectorAllston, MA Find on LinkedIn ↗
-
Jonathan Wachter · DirectorAllston, MA Find on LinkedIn ↗
-
Milton Morris · DirectorAllston, MA Find on LinkedIn ↗
-
Michael Kahana · Executive OfficerAllston, MA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗